MicroRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C

Oncogene

Volumn 31, Issue 36, 2012, Pages 4045-4053

  Datta, J ^a,b   Smith, A ^b   Lang, J C ^a,b   Islam, M ^a,b   Dutt, D ^b,c   Teknos, T N ^a,b   Pan, Q ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c VIT UNIVERSITY   (India)

Author keywords

head and neck cancer; microRNA; miR 107; protein kinase C

Indexed keywords

MICRORNA 107; PROTEIN KINASE C EPSILON;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; GENE FUNCTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEIN KINASE C-EPSILON; TUMOR BURDEN;

MUS MUSCULUS;

EID: 84866116748     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.565     Document Type: Article

References (29)

1. Avissar M, Christensen BC, Kelsey KT, Marsit CJ. (2009). MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855.
2. Ayala de la Pena F, Kanasaki K, Kanasaki M, Tangirala N, Maeda G, Kalluri R. (2011). Loss of p53 and acquisition of angiogenic microRNA profile is insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem 286: 20778-20787.
3. Aziz MH, Hafeez BB, Sand JM, Pierce DB, Aziz SW, Dreckschmidt NE et al. (2010). Protein kinase C varepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene 29: 3100-3109.
4. Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK et al. (2010). Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11: 21-28.
5. Calin GA, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
6. Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C et al. (2006). Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res 66: 6296-6303.
7. Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA et al. (2009). A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res 69: 65-74.
8. Croce CM. (2009). Causes and consequences of microRNA dysregula-tion in cancer. Nat Rev Genet 10: 704-714.
9. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S et al. (2008). Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058.
10. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA et al. (2000). Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279: L429-L438.
11. Feng L, Xie Y, Zhang H, Wu Y. (2011). miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol (doi:10.1007/s12032-011-9823-1).
12. Filipowicz W, Bhattacharyya SN, Sonenberg N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
13. Gutcher I, Webb PR, Anderson NG. (2003). The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 60: 1061-1070.
14. Hwang HW, Mendell JT. (2006). MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780.
15. Jaken S, Parker PJ. (2000). Protein kinase C binding partners. Bioessays 22: 245-254.
16. Kamangar F, Dores GM, Anderson WF. (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150.
17. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. (2008). Exploration of tumor-suppressive microRNAs silenced by DNA hypermethyla-tion in oral cancer. Cancer Res 68: 2094-2105.
18. Laramore GE, Scott CB, al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R et al. (1992). Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23: 705-713.
19. Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N et al. (2009). Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancrea-tology 9: 293-301.
20. Leemans CR, Braakhuis BJ, Brakenhoff RH. (2011). The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.
21. Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y et al. (2010). MicroRNA-107, an oncogene microRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer: MiR-107 promotes gastric cancer invasion and metastasis. J Cell Mol Med 15: 1887-1895.
22. Liu X, Jiang L, Wang A, Yu J, Shi F, Zhou X. (2009). MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 286: 217-222.
23. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S et al. (2010). A microRNA targeting dicer for metastasis control. Cell 141: 1195-1207.
24. Martinez-Gimeno C, Diaz-Meco MT, Dominguez I, Moscat J. (1995). Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: epsilon PKC, a novel prognostic factor for relapse and survival. Head Neck 17: 516-525.
25. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S et al. (2008). Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 283: 33394-33405.
26. Pan Q, Bao LW, Teknos TN, Merajver SD. (2006). Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res 66: 9379-9384.
27. Parkin DM. (2001). Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543.
28. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592.
29. Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT et al. (2010). P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 107: 6334-6339.